Background: It is estimated that 49.2% of Indonesian adolescents (10-19 years) have iron deficiency of anemia. Green vegetables can be used as an alternative consumption to meet the body's need for iron. Kelakai (Stenochlaena palustris) containing 291.32 mg-100 g of Fe has been consumed by Dayak ethnic society to prevent anemia.Objective: The aim of this study was to determine the effect of Kelakai (Stenochlaena palustris) consumptions to increase hemoglobin levels among late adolescents (17-19 years).Methods: It was a quasy-experiment with pre-test and post-test study on anemic Midwifery students (8-11 g / dl) of Betang Asi Midwifery Academy of Palangka Raya in September 2017. In which Kelakai was given as dietary supplements of the subject line and ferrous fumarate tablet as a control. There were 66 participants recruited by purposive sampling, divided into 33 subjects for each group. Kelakai (Stenochlaena palustris) (250 mg) and ferrous fumarate tablet (60 mg) were administrated daily for a week. Hemoglobin levels were measured before and after intervention using the hemoglobin testing system quick-check tool. Data were analyzed using paired and independent t-test.Result:  The result showed of significant increases on hemoglobin levels (3.24 g / dl) after consuming Kelakai (Stenochlaena palustris) for a week (p≤0.05). The hemoglobin levels after intervention in the control group were 0.03 g / dl higher than Kelakai group, but based on the analysis, there was no significant difference on both groups (p≥0.05).Conclusion: Kelakai is proven to increase hemoglobin levels. Thus, Kelakai (Stenochlaena palustris) is recommended a food supplementation to prevent iron deficiency of anemia.

ABSTRAK ABSTRACT

CKD patients must undergo regular therapy, one of them is hemodialysis. Side effects of hemodialysis therapy that are often encountered are pain and sleep quality disorders. PMR is one of the non-pharmacological therapies that can be applied to CKD patients who experience nausea and pain and impaired sleep quality. The design of this study was quasy-experimental time series design with a pre-test and post-test design with control group design. Sampling with simple random sampling technique consisted of 50 respondents in the intervention group and 50 respondents in the control group with bivariate analysis using chi square. PMR is given every day for 4 weeks. Research instruments use BPI and PSQI. The results of the study there were differences in the level of pain and sleep quality between the control group and the intervention group with a value of p <0.05. Non-pharmacological therapy for PMR can be applied to hemodialysis patients who experience pain and impaired sleep quality, so that quality of life increases